2 Dividend Stocks to Buy, and 2 to Sell
This market bounce is giving us a rare window to sell our laggards and snap up stocks that have been unfairly left behind.
Read Moreby Brett Owens, Contrarian Outlook | Apr 15, 2026
This market bounce is giving us a rare window to sell our laggards and snap up stocks that have been unfairly left behind.
Read Moreby Andrew Rocco, Zacks | Apr 15, 2026
With year-over-year revenues surging 196%, and EPS expected to soar 600% in 2026, the underlying company is at the epicenter of the AI revolution.
Read Moreby Brett Eversole, DailyWealth.com | Apr 15, 2026
The rally has begun already this month, and history says we can expect more upside to come.
Read Moreby Daniel Foelber, The Motley Fool | Apr 15, 2026
It’s a worthy foundational holding in a passive-income portfolio.
Read Moreby TheFly.com | Apr 15, 2026
Here are today’s upgrades and downgrades: Cloudfare, American Tower, SolarEdge, Autoliv, Anglo American, Symbiotic and more.
Read Moreby Rick Munarriz, The Motley Fool | Apr 14, 2026
Both with long track records of success, this could be a good time to establish or reestablish a position in these two monster names.
Read Moreby Michael Foster, Contrarian Outlook | Apr 14, 2026
Put it on your list to snap up on any major moves lower.
Read Moreby Greg Patrick, Dividends & Income | Apr 14, 2026
This is the one investment to make every week. It takes 5 minutes.
Read Moreby Tara Young and Greg Patrick, Trades of the Day | Apr 14, 2026
Our target potential upside is 14%-26% in the next 3-6 months.
Read Moreby TheFly.com | Apr 14, 2026
Here are today’s upgrades and downgrades: Tesla, Biogen, Ford, Eastman Chemical, Crocs, Birkenstock, Omega Healthcare and more.
Read Moreby Jason Fieber, Dividends And Income | Apr 13, 2026
With a market-beating yield, 50 consecutive years of dividend increases, and the potential that shares are 14% undervalued, this Dividend King could be one of the best ways for long-term dividend growth investors to play the secular growth theme in water.
Read Moreby Bryan Hayes, Zacks | Apr 13, 2026
Robust fundamentals combined with an appealing technical trend certainly justify putting this stock on your shortlist.
Read More
